Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02616 CSTONE PHARMA-B
RT Nominal up7.580 +0.660 (+9.538%)

12/06/2025 09:05

{Block Trade}CSTONE PHARMA-B: 13.4m shares, or HK$59.09m

[ET Net News Agency, 12 June 2025] 2 pre-opening trades of 13.4 million shares of CSTONE PHARMA-B (02616) were registered at 9:04a.m. The deals ... more View All

11/06/2025 09:05

{Block Trade}CSTONE PHARMA-B (02616): 66m shares, or HK$264m

[ET Net News Agency, 11 June 2025] A pre-opening trade of 66 million shares of CSTONE PHARMA-B (02616) was registered at 9:04a.m. The deal amoun ... more View All

1

Remark: Real time quote last updated: 24/07/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.